Clinical Trial Update: Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite Allergy [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial for a mite allergy treatment in rhinitis and rhinoconjunctivitis is ongoing; status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinitis
• Rhinoconjunctivitis

Snippet

Sponsor: Inmunotek S.L. | Conditions: Rhinitis, Rhinoconjunctivitis | Phase 2 | Status: UNKNOWN